Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Lovly · SciRah

Researcher profile · Semantic Scholar

C. Lovly

Share profile

C. Lovly — researcher profile on SciRah

h-index: 62
Works: 285
Citations: 17K

Most-cited papers

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
D. Ettinger, D. Wood, D. Aisner, W. Akerley +38 more
2022The Journal of the National Comprehensive Cancer Network1,156 citations
Semantic Scholar
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
D. Ettinger, D. Wood, D. Aisner, W. Akerley +34 more
2021The Journal of the National Comprehensive Cancer Network821 citations Open access
Semantic Scholar
Non-Small Cell Lung Cancer, Version 4.2024.
Gregory Riely, Douglas E. Wood, D. Ettinger, D. Aisner +41 more
2024The Journal of the National Comprehensive Cancer Network655 citations
Semantic Scholar
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
D. Ettinger, D. Wood, D. Aisner, W. Akerley +39 more
2023The Journal of the National Comprehensive Cancer Network478 citations Open access
Semantic Scholar
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
D. Chakravarty, Amber M. Johnson, J. Sklar, N. Lindeman +14 more
2022Journal of Clinical Oncology225 citations Open access
Semantic Scholar
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes
S. Heeke, C. Gay, M. Estecio, H. Tran +38 more
2024Cancer Cell134 citations Open access
Semantic Scholar
Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation
S. Sivakumar, J. Moore, M. Montesion, Radwa Sharaf +12 more
2022bioRxiv123 citations Open access
Semantic Scholar
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025.
G. Riely, Douglas E. Wood, D. Aisner, Billy W. Loo +37 more
2025The Journal of the National Comprehensive Cancer Network99 citations
Semantic Scholar
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells
L. L. Remsing Rix, N. Sumi, Q. Hu, Bina Desai +13 more
2022Science Signaling72 citations Open access
Semantic Scholar
Immunotherapy-mediated thyroid dysfunction: genetic risk and impact on outcomes with PD-1 blockade in non-small cell lung cancer
Jia Luo, V. Martucci, Z. Quandt, S. Groha +17 more
2021Clinical Cancer Research66 citations Open access
Semantic Scholar
Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
Z. Du, Benjamin P. Brown, Soyeon Kim, D. Ferguson +14 more
2021Nature Communications61 citations Open access
Semantic Scholar
Non – Small Cell Lung Cancer, Version 3.2022
D. Ettinger, D. Wood, D. Aisner, W. Akerley +39 more
202257 citations
Semantic Scholar
Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
G. Riely, Douglas E. Wood, Billy W. Loo, D. Aisner +38 more
2025The Journal of the National Comprehensive Cancer Network54 citations
Semantic Scholar
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer
S. Groves, Geena V. Ildefonso, Caitlin McAtee, P. M. M. Ozawa +22 more
2022Cell Systems50 citations Open access
Semantic Scholar
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
G. Riely, Douglas E. Wood, D. Aisner, Andrea L. Axtell +37 more
2026The Journal of the National Comprehensive Cancer Network48 citations
Semantic Scholar
Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review
A. Desai, C. Lovly
2023Translational Lung Cancer Research46 citations Open access
Semantic Scholar
Dynamics of sequence and structural cell-free DNA landscapes in small-cell lung cancer
L. Sivapalan, W. Iams, Z. Belcaid, S. Scott +11 more
2023Clinical Cancer Research41 citations Open access
Semantic Scholar
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types
P. Kasi, Jessica K. Lee, L. Pasquina, B. Decker +11 more
2023Clinical Cancer Research40 citations Open access
Semantic Scholar
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P. Selenica, A. Marra, N. Choudhury, A. Gazzo +15 more
2022Annals of Oncology39 citations Open access
Semantic Scholar
Severity of illness scores at presentation predict ICU admission and mortality in COVID-19
E. Wilfong, C. Lovly, E. Gillaspie, Li-Ching Huang +4 more
2021Journal of Emergency and Critical Care Medicine38 citations Open access
Semantic Scholar
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non–Small Cell Lung Cancer: The Phase II TRUST-I Study
Wei Li, An-Wen Xiong, N. Yang, Hui-Jie Fan +16 more
2024Journal of Clinical Oncology36 citations Open access
Semantic Scholar
My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase
Marilyn E Holt, Kathleen F. Mittendorf, M. LeNoue-Newton, Neha M. Jain +5 more
2021JCO Clinical Cancer Informatics31 citations Open access
Semantic Scholar
Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers
R. Scharpf, A. Balan, B. Ricciuti, J. Fiksel +20 more
2022Cancer Research30 citations Open access
Semantic Scholar
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
D. Ettinger, Douglas E. Wood, J. Stevenson, D. Aisner +39 more
2023The Journal of the National Comprehensive Cancer Network29 citations Open access
Semantic Scholar
Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer
Benjamin P. Brown, Yun-Kai Zhang, Soyeon Kim, P. Finneran +8 more
2022bioRxiv28 citations Open access
Semantic Scholar
Mesothelioma: Pleural, Version 1.2024.
J. Stevenson, D. Ettinger, Douglas E. Wood, D. Aisner +41 more
2024The Journal of the National Comprehensive Cancer Network27 citations Open access
Semantic Scholar
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Pooja Middha, R. Thummalapalli, M. Betti, Lydia Yao +28 more
2024Nature Communications27 citations Open access
Semantic Scholar
Expanding Horizons for Treatment of Early-Stage Lung Cancer.
C. Lovly
2022New England Journal of Medicine25 citations
Semantic Scholar
Beyond PD-L1: B7-H6 emerges as a potential immunotherapy target in small cell lung cancer
P. Thomas, S. Groves, Yun-Kai Zhang, Jia Li +15 more
2021Journal of Thoracic Oncology23 citations Open access
Semantic Scholar
Real-world ALK Testing Trends in Patients With Advanced Non-Small-Cell Lung Cancer in the United States.
H. Lin, Yanyu Wu, Yu Yin, H. Niu +3 more
2022Clinical Lung Cancer16 citations Open access
Semantic Scholar
Cancer Hallmarks Define a Continuum of Plastic Cell States between Small Cell Lung Cancer Archetypes
S. Groves, A. Ireland, Qi Liu, A. Simmons +6 more
2021bioRxiv16 citations Open access
Semantic Scholar
Ferrying Oncologists Across the Chasm of Interpreting Biomarker Testing Reports: Systematic Support Needed to Improve Care and Decrease Disparities.
H. West, C. Lovly
2023JCO Oncology Practice15 citations Open access
Semantic Scholar
Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
A. Desai, C. Lovly
2023Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
Randomized phase III Trial of MEDI4736 (durvalumab) as concurrent and consolidative therapy or consolidative therapy alone for unresectable stage 3 NSCLC: A trial of the ECOG-ACRIN Cancer Research Group (EA5181).
J. Varlotto, Zhuo-Xin Sun, S. Ramalingam, H. Wakelee +4 more
202114 citations
Semantic Scholar
PL03.06 EA5181: Phase 3 Trial of Concurrent and Consolidative Durvalumab vs Consolidation Durva Alone for Unresectable Stage 3 NSCLC
J. Varlotto, Y. Xie, N. Pennell, K. Oettel +25 more
2025Journal of Thoracic Oncology13 citations Open access
Semantic Scholar
Framework for Implementing and Tracking A Molecular Tumor Board at an NCI-Designated Comprehensive Cancer Center.
Neha M. Jain, L. Schmalz, C. Cann, M. B. A. Adara Holland +11 more
2021The Oncologist13 citations Open access
Semantic Scholar
Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics
C. Tydings, Bhuminder Singh, Adam W. Smith, K. Ledwitch +4 more
2024Protein Science12 citations Open access
Semantic Scholar
Perioperative Immunotherapy - A KEY toward Improved Outcomes for Early-Stage Lung Cancer?
C. Lovly
2023New England Journal of Medicine11 citations
Semantic Scholar
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
Pooja Middha, R. Thummalapalli, Z. Quandt, K. Balaratnam +13 more
2024Journal for ImmunoTherapy of Cancer10 citations Open access
Semantic Scholar
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors
Hiroki Sato, Daisuke Kubota, H. Qiao, A. Jungbluth +9 more
2022JCO Precision Oncology10 citations Open access
Semantic Scholar
Alpha-T: An innovative decentralized (home-based) phase 2 trial of alectinib in ALK-positive (ALK+) solid tumors in a histology-agnostic setting.
R. Kurzrock, A. Mackenzie, A. Jurdi, B. Goueli +9 more
202110 citations
Semantic Scholar
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.
Christina M. Lockwood, H. Messersmith, Annette S. Kim, P. Rajagopal +13 more
2026JCO Oncology Practice8 citations
Semantic Scholar
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease.
Jessica J. Lin, J. Gainor, Vincent K. Lam, C. Lovly
2024Cancer Discovery8 citations
Semantic Scholar
Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform
Richard L Martin, Michael Grant, ST Kimani, S. Midha +27 more
2021JCO Oncology Practice8 citations Open access
Semantic Scholar
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Pooja Middha, R. Thummalapalli, M. Betti, Lydia Yao +23 more
2023medRxiv7 citations Open access
Semantic Scholar
A review of immunotherapy for stage 3 and metastatic NSCLC & the rationale for the ECOG-ACRIN EA5181 study.
J. Varlotto, Zhuo-Xin Sun, B. Ky, J. Upshaw +11 more
2021The Oncologist7 citations Open access
Semantic Scholar
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute – Designated Comprehensive Cancer Center
M., Jain, L. Schmalz, C. Cann +16 more
20216 citations
Semantic Scholar
A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.
J. Varlotto, Zhuo-Xin Sun, B. Ky, J. Upshaw +10 more
2022Clinical Lung Cancer5 citations
Semantic Scholar
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E
Monica F. Chen, Zi-He Song, H. Yu, L. Sequist +18 more
2024JCO Precision Oncology4 citations
Semantic Scholar
A new benchmark for targeted therapies in lung cancer - median PFS for Lorlatinib in advanced ALK+ NSCLC surpasses 5 years
C. Lovly
2024Journal of Clinical Oncology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Gubens×14
Invite
M. Gubens — researcher profile on SciRah
D. Aisner×11
Invite
D. Aisner — researcher profile on SciRah
A. Bharat×10
Invite
A. Bharat — researcher profile on SciRah
T. Dilling×10
Invite
T. Dilling — researcher profile on SciRah

×10

Invite

R. Lackner — researcher profile on SciRah

Invite

A. Tam — researcher profile on SciRah

Invite

K. Gregory — researcher profile on SciRah

S. Gettinger×9

Invite

S. Gettinger — researcher profile on SciRah

Invite

T. Grotz — researcher profile on SciRah

Gregory Riely×9

Invite

Gregory Riely — researcher profile on SciRah

Invite

W. Akerley — researcher profile on SciRah

Invite

L. Chirieac — researcher profile on SciRah